Neogenomics Inc
Change company Symbol lookup
Select an option...
NEO Neogenomics Inc
GPN Global Payments Inc
HARP Harpoon Therapeutics Inc
VIRC Virco Mfg Corp
RVLP RVL Pharmaceuticals PLC
TRGP Targa Resources Corp
RCRT Recruiter.Com Group Inc
VGAS Verde Clean Fuels Inc
DHHC DiamondHead Holdings Corp
EJH E-Home Household Service Holdings Ltd
Go

Health Care : Health Care Providers & Services | Small Cap Blend

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories. The Company operates through two segments: the Clinical Services Segment and the Pharma Services Segment. The Clinical Services segment provides various clinical testing services to community-based pathology practices, oncology practices, hospital pathology labs, reference labs, and academic centers with reimbursement from various payers, including client direct billing, commercial insurance, Medicare and other government payers, and patients. The Pharma Services segment supports pharmaceutical firms in their drug development programs by providing testing services and data analytics for clinical trials and research. The Company offers testing services, which include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry (IHC) and digital imaging, molecular testing and morphologic analysis. It operates testing laboratories in United States, Europe and Asia.

Closing Price: $16.87

Day's Change: -1.29 (-7.10%)

Bid: --

Ask: --

B/A Size: --

Day's High: 17.80

Day's Low: 16.70

Volume (Heavy Day) Volume: 1,559,657 10-day average volume: 1,264,651: 1,559,657

March 22, 2023
8:00 am ET	Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient Care Massive Bio, Inc., a private AI-enabled oncology startup that provides virtual and in-person concierge services for cancer patients, and NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services and global...(BusinessWire)
March 17, 2023
5:00 pm ET	Lifshitz Law PLLC Announces Investigations of Generac Holdings Inc. (NYSE: GNRC), Veru Inc. (NASDAQ: VERU), The Gap, Inc. (NYSE: GPS), and NeoGenomics, Inc. (NASDAQ: NEO)(Globe Newswire)
March 16, 2023
7:00 am ET	NeoGenomics Announces Commercial Availability of the RaDaR(R) Molecular Residual Disease Test FT MYERS, FL / ACCESSWIRE / March 16, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, announced today the commercial availability of the RaDaR® assay, a liquid biopsy test for...(Accesswire)
March 13, 2023
7:00 am ET	NeoGenomics Expands NGS Portfolio with Launch of Neo Comprehensive(TM) - Solid Tumor CGP and Neo Comprehensive(TM) - Myeloid Disorders CGP FT. MYERS, FL / ACCESSWIRE / March 13, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, announced today the expansion of their next-generation sequencing (NGS) portfolio of...(Accesswire)
February 28, 2023
7:00 am ET	NeoGenomics to Present at the 44th Annual Raymond James Institutional Investors Conference FT. MYERS, FL / ACCESSWIRE / February 28, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that Chris Smith, chief executive officer...(Accesswire)
February 23, 2023
7:01 am ET	NeoGenomics Reports Fourth Quarter and Full Year 2022 Results Fourth Quarter Revenue Increased 10% to $139 million; Full Year Revenue Increased 5% to $510 million FORT MYERS, FL / ACCESSWIRE / February 23, 2023 / NeoGenomics, Inc. (NASDAQ:NEO) (the "Company") , a leading provider of oncology testing and...(Accesswire)
February 21, 2023
9:20 am ET	Investors who lost money with shares of NeoGenomics, Inc. (NASDAQ: NEO) should contact the Shareholders Foundation in connection with the Lawsuit against NeoGenomics, Inc.(Globe Newswire)
February 06, 2023
10:00 am ET	DEADLINE ALERT for VERU and NEO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders(Globe Newswire)
7:00 am ET	NeoGenomics Schedules its Fourth Quarter and Full Year 2022 Earnings Release for February 23, 2023 FT. MYERS, FL / ACCESSWIRE / February 6, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, announced today that it plans to release its fourth quarter and full year 2022, financial...(Accesswire)
7:00 am ET	RaDaR(R) Assay Demonstrates Clinical Potential for Helping Oncologists Determine Whether or Not Muscle-Invasive Bladder Cancer Patients Undergo Radical Surgery Newly-published data shows a strong link between tumor DNA circulating in blood and patient responses to investigational neoadjuvant treatment with immune therapies FT. MYERS, FL / ACCESSWIRE / February 6, 2023 / NeoGenomics, Inc. (NASDAQ:NEO)...(Accesswire)
February 05, 2023
9:00 pm ET	NEOGENOMICS 24 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO NEW ORLEANS, LA / ACCESSWIRE / February 5, 2023 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 6, 2023 to file lead plaintiff...(Accesswire)
10:06 am ET	DEADLINE APPROACHING: Berger Montague Advises Investors That A Securities Fraud Class Action Lawsuit Was Filed Against NEOGENOMICS, INC. (NASDAQ:NEO); Lead Plaintiff Deadline is February 6, 2023 PHILADELPHIA, PA / ACCESSWIRE / February 5, 2023 / Berger Montague advises investors that a securities fraud class action lawsuit has been filed against NeoGenomics Inc. ("NeoGenomics") (NASDAQ:NEO) on behalf of those who purchased NeoGenomics...(Accesswire)
February 04, 2023
10:03 pm ET	NEOGENOMICS 48 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO NEW ORLEANS, LA / ACCESSWIRE / February 4. 2023 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 6, 2023 to file lead plaintiff...(Accesswire)
10:32 am ET	INVESTOR REMINDER: NEOGENOMICS, INC. (NASDAQ:NEO). Berger Montague Advises Investors to Inquire About a Securities Fraud Action by February 6, 2023 PHILADELPHIA, PA / ACCESSWIRE / February 4, 2023 / Berger Montague advises investors that a securities fraud class action lawsuit has been filed against NeoGenomics Inc. ("NeoGenomics") (NASDAQ:NEO) on behalf of those who purchased NeoGenomics...(Accesswire)
February 03, 2023
10:50 pm ET	NEOGENOMICS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess Of $100,000 of Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 6, 2023 to file lead plaintiff applications in a securities class action lawsuit...(BusinessWire)
9:00 pm ET	Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against F45 Training, Silvergate, NeoGenomics, and Iris and Encourages Investors to Contact the Firm(Globe Newswire)
9:00 pm ET	NEOGENOMICS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against NeoGenomics, Inc. and Encourages Investors to Contact the Firm Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO) in the United States District...(BusinessWire)
1:00 pm ET	The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NeoGenomics, Inc. (NEO) The Law Offices of Frank R. Cruz reminds investors of the upcoming February 6, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ...(BusinessWire)
10:46 am ET	CLASS ACTION UPDATE for GPS, NEO and ARBK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders NEW YORK, NY / ACCESSWIRE / February 3, 2023 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff...(Accesswire)
February 02, 2023
10:51 pm ET	NEOGENOMICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO NEW ORLEANS, LA / ACCESSWIRE / February 2, 2023 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have untilFebruary 6, 2023 to file lead plaintiff...(Accesswire)
Next >

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and